HOWARD PHARMACY (LA PORTE PRECINCT) LIMITED

🌿Early-stageactive
SC778189 · ltd · incorporated 2023-08-07
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
Upgrade to see
Turnover
year to Feb 2025
Net worth
£385.5k
book net assets
Opportunity
71/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Dispensing chemist in specialised stores
Sector: Wholesale & retail
Investor take
Pursue
Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 71/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (58/100).

🏦

Refinance opportunity

1 live charge · oldest 2.7y

50/100
clean up first

Refinance viable after a tidy-up — address the highlighted items first.

  • · Newest facility, 2.7 years old — likely still in initial term.
  • · Single lender — cleanest path to refinance.
  • · Legal-friction score 15/100 — clean.

Data confidence

Overall: high (80/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
1 charges (1/1 with lender, 1/1 with type)
90
Directors & officers
2 officers (1 active, 2 linked, 2 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
1 connected companies via shared directors
48
Filing history
19 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
71/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
100
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Positive net assets
Net assets £385,527
Cash YoY
+39%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£410k
↑ 39% YoY
Net Worth
£386k
↑ 30% YoY
Current Assets
£781k
↑ 21% YoY
Current Liabilities
£0£156k£313k£469k£625k£781kFeb 2024Feb 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2025-02-282024-02-29
Total assets£970.0k£1.16M
Current assets£781.4k£643.3k
Cash£409.6k£293.9k
Debtors£288.9k£269.7k
Net assets£385.5k£296.4k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
1
filing
  • 1 capital
Last 180 days
3
filings
  • 1 capital
  • 1 resolution
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (22 events)Click to expand
  1. 2026-02-18
    📄
    capital-name-of-class-of-shares
    capital · SH08
  2. 2026-02-13
    📄
    resolution
    resolution · RESOLUTIONS
  3. 2025-11-28
    📄
    accounts-with-accounts-type-small
    accounts · AA
  4. 2025-10-23
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  5. 2025-10-14
    MCDOWALL, Gordon resigned
    director
  6. 2025-03-18
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  7. 2024-11-26
    📄
    accounts-with-accounts-type-small
    accounts · AA
  8. 2024-11-20
    MCDOWALL, Craig Howard appointed
    director
  9. 2024-03-06
    📄
    capital-variation-of-rights-attached-to-shares
    capital · SH10
  10. 2024-03-06
    📄
    capital-name-of-class-of-shares
    capital · SH08
  11. 2024-03-05
    📄
    memorandum-articles
    incorporation · MA
  12. 2024-03-05
    📄
    resolution
    resolution · RESOLUTIONS
  13. 2024-02-26
    📄
    change-account-reference-date-company-current-shortened
    accounts · AA01
  14. 2023-09-12
    📄
    mortgage-create-with-deed-with-charge-number-charge-creation-date
    mortgage · MR01
  15. 2023-09-11
    📄
    memorandum-articles
    incorporation · MA
  16. 2023-09-11
    📄
    resolution
    resolution · RESOLUTIONS
  17. 2023-09-11
    📄
    capital-allotment-shares
    capital · SH01
  18. 2023-09-07
    🔒
    Charge registered #1
    Lender: The Royal Bank of Scotland PLC
  19. 2023-08-23
    ✏️
    certificate-change-of-name-company
    change-of-name · CERTNM
  20. 2023-08-07
    🏢
    Company incorporated
    As HOWARD PHARMACY (LA PORTE PRECINCT) LIMITED
  21. 2023-08-07
    MCDOWALL, Gordon appointed
    director
  22. 2023-08-07
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

80/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Young company: Only 2.8 years old — management layer unlikely to be developed.

Succession & seller-readiness

45/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Group structure

Aver Generics Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.

🏛️
Aver Generics Limited
Corporate parent · holds 75-100% shares · board control
ultimate parent
HOWARD PHARMACY (LA PORTE PRECINCT) LIMITED
This company · SC778189

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Aver Generics Limited
Corporate entity
75100%
75–100%board control75-100% shares · 75-100% voting · board control07/08/2023

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Retail · G postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
HOUSE OF IYANU LTD
SC863163 · est 2025 · no financials extracted
HOUSE OF MUSA LIMITED
SC824502 · est 2024 · no financials extracted
1y
HOUSE OF NAV LIMITED
SC867462 · est 2025 · no financials extracted
HS DISTRIBUTORS LTD
SC546767 · est 2016 · no financials extracted
9y
HSA MPHARM LTD
SC766455 · est 2023 · no financials extracted
2y
HUBBA HUBBA LIMITED
SC717120 · est 2021 · no financials extracted
4y
HUNT VINTAGE LTD
SC662248 · est 2020 · no financials extracted
5y
HUSHMART LTD
SC758358 · est 2023 · no financials extracted
3y
HUSTO2 LTD
SC852000 · est 2025 · no financials extracted
HUZZY LTD
SC862145 · est 2025 · no financials extracted
HY TRADERS LTD
SC871471 · est 2025 · no financials extracted
HYKES ENTERPRISE COMMERCE LIMITED
SC813915 · est 2024 · no financials extracted
1y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2023-08-07
Jurisdictionscotland
Primary SIC47730 — Dispensing chemist in specialised stores

Registered office

20 Singer Road
East Kilbride
Glasgow
G75 0XS
Scotland

Filing status

Accounts
Next due: 2026-11-30
Last made up to: 2025-02-28
Confirmation statement
Next due: 2026-08-20
Last: 2025-08-06

Officers (1 active · 1 resigned)

MCDOWALL, Craig Howard
director · ~36y · appointed 2024-11-20
View their other companies + combined net worth →
Active
MCDOWALL, Gordon
director · ~68y · appointed 2023-08-07 · resigned 2025-10-14
Resigned

Click a director name to see their full track record across all companies.

Mortgages & charges

1
Total charges
1
Outstanding
1
Active lenders
Status:Lender:1 of 1 shown
TypeProperties
outstanding
Lloyds Banking Group
The Royal Bank of Scotland PLC
A registered charge07/09/2023
Click column headers to sort. Use filters above to narrow by status and lender.

Recent filings (19 total)

capital-name-of-class-of-shares
capital · SH08
2026-02-18
resolution
resolution · RESOLUTIONS
2026-02-13
accounts-with-accounts-type-small
accounts · AA
2025-11-28
termination-director-company-with-name-termination-date
officers · TM01
2025-10-23
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-08-12
appoint-person-director-company-with-name-date
officers · AP01
2025-03-18
accounts-with-accounts-type-small
accounts · AA
2024-11-26
confirmation-statement-with-updates
confirmation-statement · CS01
2024-08-15
capital-variation-of-rights-attached-to-shares
capital · SH10
2024-03-06
capital-name-of-class-of-shares
capital · SH08
2024-03-06
memorandum-articles
incorporation · MA
2024-03-05
resolution
resolution · RESOLUTIONS
2024-03-05
change-account-reference-date-company-current-shortened
accounts · AA01
2024-02-26
mortgage-create-with-deed-with-charge-number-charge-creation-date
mortgage · MR01
2023-09-12
memorandum-articles
incorporation · MA
2023-09-11